Clinical Trial 49092

Tucson, AZ 85704


ModernaTX, Inc. / “A Phase 3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants.

Qualified Participants Must:

• Female Participants 18 to 40 Years of Age

Qualified Participants May Receive:

Compensation up to $1900 for 14 visits over 2.5 years. 

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.